Alkermes - 33 Year Stock Price History | ALKS

Historical daily share price chart and data for Alkermes since 1991 adjusted for splits and dividends. The latest closing stock price for Alkermes as of May 17, 2024 is 24.15.
  • The all-time high Alkermes stock closing price was 98.05 on March 01, 2000.
  • The Alkermes 52-week high stock price is 33.71, which is 39.6% above the current share price.
  • The Alkermes 52-week low stock price is 22.01, which is 8.9% below the current share price.
  • The average Alkermes stock price for the last 52 weeks is 27.81.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Alkermes Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 27.0710 28.6200 32.5600 23.7600 24.1500 -12.94%
2023 28.1991 25.8700 33.6300 23.3700 27.7400 6.16%
2022 25.8508 24.1500 31.8700 21.9400 26.1300 12.34%
2021 24.3680 19.7400 32.1300 18.2100 23.2600 16.59%
2020 17.6377 19.7600 22.1000 13.0600 19.9500 -2.21%
2019 25.4200 29.1100 37.3300 17.2900 20.4000 -30.87%
2018 45.9911 55.2200 67.2600 27.9400 29.5100 -46.08%
2017 54.8201 56.1000 61.6600 47.6900 54.7300 -1.53%
2016 45.4797 74.8300 75.2700 29.0500 55.5800 -29.98%
2015 66.3880 58.2400 80.1400 55.0800 79.3800 35.55%
2014 47.3686 40.2400 58.8800 40.0700 58.5600 44.02%
2013 30.2678 19.2800 41.1200 19.2800 40.6600 119.55%
2012 18.1842 17.3400 20.8800 15.1200 18.5200 6.68%
2011 15.4301 12.5500 19.5200 12.1400 17.3600 41.37%
2010 12.4457 9.7100 15.9200 9.6900 12.2800 30.50%
2009 9.6079 10.7100 13.1300 7.5600 9.4100 -11.64%
2008 12.2140 15.1000 16.8900 6.1000 10.6500 -31.69%
2007 15.7875 13.0900 18.5600 12.7600 15.5900 16.60%
2006 18.9792 20.5200 26.7100 13.1800 13.3700 -30.07%
2005 14.4015 14.0100 19.6600 10.0100 19.1200 35.70%
2004 13.3925 13.9700 16.8600 8.5100 14.0900 4.37%
2003 11.0874 6.6600 15.5600 6.5200 13.5000 115.31%
2002 15.1033 25.7500 30.3400 3.7800 6.2700 -76.21%
2001 26.8799 27.6300 37.1000 17.5000 26.3600 -16.00%
2000 41.5542 25.5000 98.0500 23.6250 31.3800 27.74%
1999 15.7511 11.6900 26.8150 11.4400 24.5650 121.41%
1998 9.9991 9.9400 13.3750 5.3150 11.0950 11.62%
1997 9.5169 11.1900 14.6900 5.1900 9.9400 -14.49%
1996 6.2174 3.7500 12.1250 3.7500 11.6250 192.89%
1995 2.4000 1.0315 4.3125 1.0000 3.9690 273.55%
1994 2.4714 3.6875 4.5000 1.0625 1.0625 -69.64%
1993 4.1401 4.5000 5.5000 3.1250 3.5000 -17.65%
1992 6.0673 9.0000 14.1900 2.7500 4.2500 -52.78%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.087B $1.663B
Alkermes plc, formed by the merger of Waltham, MA-based Alkermes, Inc. and Elan Drug Technologies (EDT), is a fully integrated global biopharmaceutical company that utilizes proprietary technologies to research, develop and commercialize, both with partners and on its own pharmaceutical products in major therapeutic areas. Alkermes holds a diversified product portfolio and a promising pipeline of candidates targeting major central nervous system (CNS) disorders including schizophrenia, depression, addiction and multiple sclerosis. Alkermes derives revenues on net sales of its proprietary products: Vivitrol & Aristada, and manufacturing and/or royalty revenues on net sales of products commercialized by the company's partners. These include Risperdal Consta, Invega Sustenna/Xeplion, Invega Trinza/Trevicta, Ampyra/Fampyra and Bydureon. Interesting late-stage candidate in the company's pipeline include nemvaleukin alfa developed for treating advanced solid tumors. Its proprietary drugs are Vivitrol & Aristada.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $167.620B 16.77
Vertex Pharmaceuticals (VRTX) United States $114.888B 29.56
Regeneron Pharmaceuticals (REGN) United States $108.235B 26.47
GSK (GSK) United Kingdom $93.218B 11.13
CSL (CSLLY) Australia $90.861B 0.00
Bristol Myers Squibb (BMY) United States $89.253B 41.93
Gilead Sciences (GILD) United States $84.369B 16.80
Moderna (MRNA) United States $50.933B 0.00
Biogen (BIIB) United States $33.570B 15.37
Argenex SE (ARGX) Netherlands $21.740B 0.00
BioNTech SE (BNTX) Germany $21.540B 181.22
Genmab (GMAB) Denmark $19.824B 23.24
Alnylam Pharmaceuticals (ALNY) United States $18.898B 0.00
Illumina (ILMN) United States $17.693B 126.22
BeiGene (BGNE) Cayman Islands $16.540B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.727B 57.45
Bio-Techne Corp (TECH) United States $13.206B 49.88
Incyte (INCY) United States $12.821B 19.83
Sarepta Therapeutics (SRPT) United States $12.419B 1094.83
QIAGEN (QGEN) Netherlands $10.427B 22.27
Repligen (RGEN) United States $9.607B 125.50
Exact Sciences (EXAS) United States $9.297B 0.00
Roivant Sciences (ROIV) United Kingdom $9.050B 0.00
Legend Biotech (LEGN) United States $8.215B 0.00
Vaxcyte (PCVX) United States $8.113B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.984B 26.11
Viking Therapeutics (VKTX) United States $7.388B 0.00
Ascendis Pharma (ASND) Denmark $7.052B 0.00
Intra-Cellular Therapies (ITCI) United States $6.862B 0.00
Blueprint Medicines (BPMC) United States $6.572B 0.00
Exelixis (EXEL) United States $6.340B 32.67
Cytokinetics (CYTK) United States $6.242B 0.00
Halozyme Therapeutics (HALO) United States $5.690B 15.80
ImmunityBio (IBRX) United States $5.291B 0.00
Apellis Pharmaceuticals (APLS) United States $5.014B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.774B 0.00
Krystal Biotech (KRYS) United States $4.686B 0.00
Nuvalent (NUVL) United States $4.541B 0.00
Zealand Pharma (ZLDPF) Denmark $4.510B 0.00
Immunovant (IMVT) United States $4.461B 0.00
Insmed (INSM) United States $3.681B 0.00
Axsome Therapeutics (AXSM) United States $3.635B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.515B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.481B 0.00
SpringWorks Therapeutics (SWTX) United States $3.322B 0.00
Biohaven (BHVN) United States $3.299B 0.00
Guardant Health (GH) United States $3.103B 0.00
IDEAYA Biosciences (IDYA) United States $3.065B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.004B 0.00
Apogee Therapeutics (APGE) United States $2.941B 0.00
Denali Therapeutics (DNLI) United States $2.925B 0.00
Arcellx (ACLX) United States $2.869B 0.00
Iovance Biotherapeutics (IOVA) United States $2.865B 0.00
MorphoSys AG (MOR) Germany $2.862B 0.00
Amicus Therapeutics (FOLD) United States $2.835B 0.00
Avidity Biosciences (RNA) United States $2.821B 0.00
Twist Bioscience (TWST) United States $2.737B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.665B 0.00
Certara (CERT) United States $2.586B 59.56
Merus (MRUS) Netherlands $2.577B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.540B 0.00
Intellia Therapeutics (NTLA) United States $2.530B 0.00
Celldex Therapeutics (CLDX) United States $2.518B 0.00
Fortrea Holdings (FTRE) United States $2.462B 30.27
ACADIA Pharmaceuticals (ACAD) United States $2.444B 0.00
Janux Therapeutics (JANX) United States $2.442B 0.00
Vericel (VCEL) United States $2.350B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.315B 0.00
Myriad Genetics (MYGN) United States $2.289B 0.00
Geron (GERN) United States $2.260B 0.00
Vera Therapeutics (VERA) United States $2.254B 0.00
Arvinas (ARVN) United States $2.236B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.202B 0.00
Kymera Therapeutics (KYMR) United States $2.144B 0.00
ADMA Biologics Inc (ADMA) United States $2.102B 83.73
Rocket Pharmaceuticals (RCKT) United States $2.053B 0.00
Beam Therapeutics (BEAM) United States $2.027B 0.00
Bavarian Nordic (BVNRY) Denmark $2.026B 8.82
CG Oncology (CGON) United States $1.998B 0.00
Galapagos (GLPG) Belgium $1.953B 0.00
Sana Biotechnology (SANA) United States $1.934B 0.00
Zai Lab (ZLAB) China $1.925B 0.00
NeoGenomics (NEO) United States $1.890B 0.00
Keros Therapeutics (KROS) United States $1.886B 0.00
Novavax (NVAX) United States $1.827B 0.00
Inhibrx (INBX) United States $1.818B 0.00
Protagonist Therapeutics (PTGX) United States $1.803B 12.60
Ginkgo Bioworks Holdings (DNA) United States $1.734B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.724B 0.00
Edgewise Therapeutics (EWTX) United States $1.691B 0.00
Kura Oncology (KURA) United States $1.689B 0.00
Structure Therapeutics (GPCR) United States $1.685B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.649B 12.57
Ligand Pharmaceuticals (LGND) United States $1.549B 25.31
Neumora Therapeutics (NMRA) United States $1.543B 0.00
Arcus Biosciences (RCUS) United States $1.537B 0.00
Spyre Therapeutics (SYRE) United States $1.523B 0.00
Morphic Holding (MORF) United States $1.464B 0.00
Dynavax Technologies (DVAX) United States $1.454B 185.17
Tarsus Pharmaceuticals (TARS) United States $1.445B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.413B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.402B 0.00
Akero Therapeutics (AKRO) United States $1.377B 0.00
Vir Biotechnology (VIR) United States $1.324B 0.00
Belite Bio (BLTE) United States $1.311B 0.00
ANI Pharmaceuticals (ANIP) United States $1.288B 16.00
MannKind (MNKD) United States $1.250B 153.00
Gyre Therapeutics (GYRE) United States $1.218B 0.00
Prothena (PRTA) Ireland $1.211B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.167B 0.00
MiMedx (MDXG) United States $1.151B 48.75
Mirum Pharmaceuticals (MIRM) United States $1.134B 0.00
AbCellera Biologics (ABCL) Canada $1.070B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.065B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.051B 0.00
Cullinan Therapeutics (CGEM) United States $0.998B 0.00
Scholar Rock Holding (SRRK) United States $0.996B 0.00
Liquidia Technologies (LQDA) United States $0.971B 0.00
Tyra Biosciences (TYRA) United States $0.959B 0.00
Immatics (IMTX) Germany $0.928B 0.00
Pliant Therapeutics (PLRX) United States $0.921B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.914B 0.00
Viridian Therapeutics (VRDN) United States $0.858B 0.00
Abivax SA (ABVX) France $0.858B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.857B 0.00
Prime Medicine (PRME) United States $0.850B 0.00
89BIO (ETNB) United States $0.849B 0.00
Mesoblast (MESO) Australia $0.839B 0.00
Immunome (IMNM) United States $0.829B 0.00
Nurix Therapeutics (NRIX) United States $0.815B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.804B 0.00
CARGO Therapeutics (CRGX) United States $0.804B 0.00
Tango Therapeutics (TNGX) United States $0.803B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.802B 0.00
Cytek Biosciences (CTKB) United States $0.801B 0.00
Disc Medicine (IRON) United States $0.794B 0.00
REGENXBIO (RGNX) United States $0.788B 0.00
HilleVax (HLVX) United States $0.788B 0.00
CureVac (CVAC) Germany $0.781B 0.00
Praxis Precision Medicines (PRAX) United States $0.777B 0.00
PureTech Health (PRTC) United States $0.776B 0.00
WAVE Life Sciences (WVE) Singapore $0.767B 0.00
Humacyte (HUMA) United States $0.754B 0.00
Dianthus Therapeutics (DNTH) United States $0.752B 0.00
ALX Oncology Holdings (ALXO) United States $0.740B 0.00
Stoke Therapeutics (STOK) United States $0.724B 0.00
Nuvation Bio (NUVB) United States $0.724B 0.00
Cogent Biosciences (COGT) United States $0.711B 0.00
AnaptysBio (ANAB) United States $0.685B 0.00
ArriVent BioPharma (AVBP) United States $0.673B 0.00
Castle Biosciences (CSTL) United States $0.669B 0.00
Kyverna Therapeutics (KYTX) United States $0.665B 0.00
GH Research (GHRS) Ireland $0.656B 0.00
ITeos Therapeutics (ITOS) United States $0.652B 0.00
Mineralys Therapeutics (MLYS) United States $0.645B 0.00
Zymeworks (ZYME) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Pharming Group (PHAR) Netherlands $0.626B 0.00
Pharming Group (PHGUF) Netherlands $0.622B 0.00
Oric Pharmaceuticals (ORIC) United States $0.618B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.617B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.617B 0.00
Cabaletta Bio (CABA) United States $0.596B 0.00
Aerovate Therapeutics (AVTE) United States $0.593B 0.00
Avid Bioservices (CDMO) United States $0.579B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.578B 0.00
Third Harmonic Bio (THRD) United States $0.568B 0.00
EnGene Holdings (ENGN) United States $0.566B 0.00
Northwest Biotherapeutics (NWBO) United States $0.564B 0.00
Arbutus Biopharma (ABUS) United States $0.562B 0.00
Olema Pharmaceuticals (OLMA) United States $0.550B 0.00
IGM Biosciences (IGMS) United States $0.544B 0.00
Adaptive Biotechnologies (ADPT) United States $0.532B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Alector (ALEC) United States $0.524B 0.00
Astria Therapeutics (ATXS) United States $0.524B 0.00
Celcuity (CELC) United States $0.523B 0.00
Absci (ABSI) United States $0.522B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.509B 0.00
Entrada Therapeutics (TRDA) United States $0.506B 23.79
Ocugen (OCGN) United States $0.492B 0.00
Adlai Nortye (ANL) Cayman Islands $0.489B 0.00
MaxCyte (MXCT) United States $0.488B 0.00
Oculis Holding AG (OCS) Switzerland $0.485B 0.00
Applied Therapeutics (APLT) United States $0.479B 0.00
TScan Therapeutics (TCRX) United States $0.475B 0.00
Allogene Therapeutics (ALLO) United States $0.473B 0.00
Fulcrum Therapeutics (FULC) United States $0.469B 0.00
Editas Medicine (EDIT) United States $0.462B 0.00
Travere Therapeutics (TVTX) United States $0.461B 0.00
Voyager Therapeutics (VYGR) United States $0.459B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.449B 0.00
Fate Therapeutics (FATE) United States $0.444B 0.00
Biomea Fusion (BMEA) United States $0.440B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.436B 0.00
ACELYRIN, INC (SLRN) United States $0.435B 0.00
Neurogene (NGNE) United States $0.432B 0.00
PepGen (PEPG) United States $0.427B 0.00
Annexon (ANNX) United States $0.400B 0.00
Replimune (REPL) United States $0.395B 0.00
C4 Therapeutics (CCCC) United States $0.391B 0.00
Anavex Life Sciences (AVXL) United States $0.385B 0.00
Terns Pharmaceuticals (TERN) United States $0.382B 0.00
Anika Therapeutics (ANIK) United States $0.377B 317.50
Shattuck Labs (STTK) United States $0.376B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.372B 0.00
FibroBiologics (FBLG) United States $0.371B 0.00
Nautilus Biotechnology (NAUT) United States $0.370B 0.00
MeiraGTx Holdings (MGTX) United States $0.367B 0.00
Tenaya Therapeutics (TNYA) United States $0.366B 0.00
Aura Biosciences (AURA) United States $0.360B 0.00
Amarin (AMRN) Ireland $0.357B 0.00
Precigen (PGEN) United States $0.348B 0.00
Jasper Therapeutics (JSPR) United States $0.347B 0.00
Solid Biosciences (SLDB) United States $0.343B 0.00
Candel Therapeutics (CADL) United States $0.342B 0.00
Erasca (ERAS) United States $0.342B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.339B 0.00
Skye Bioscience (SKYE) United States $0.338B 0.00
Alto Neuroscience (ANRO) United States $0.335B 0.00
Mersana Therapeutics (MRSN) United States $0.334B 0.00
Ventyx Biosciences (VTYX) United States $0.333B 0.00
Sutro Biopharma (STRO) United States $0.328B 0.00
Nkarta (NKTX) United States $0.323B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.319B 0.00
Revance Therapeutics (RVNC) United States $0.315B 0.00
AC Immune (ACIU) Switzerland $0.315B 0.00
Inovio Pharmaceuticals (INO) United States $0.311B 0.00
Urogen Pharma (URGN) United States $0.310B 0.00
Poseida Therapeutics (PSTX) United States $0.309B 0.00
Kamada (KMDA) Israel $0.309B 23.35
Atea Pharmaceuticals (AVIR) United States $0.307B 0.00
Caribou Biosciences (CRBU) United States $0.306B 0.00
XOMA (XOMA) United States $0.297B 0.00
Verastem (VSTM) United States $0.291B 0.00
Emergent Biosolutions (EBS) United States $0.291B 0.00
Invivyd (IVVD) United States $0.286B 0.00
Inozyme Pharma (INZY) United States $0.285B 0.00
23andMe Holding (ME) United States $0.283B 0.00
Contineum Therapeutics (CTNM) United States $0.283B 0.00
CorMedix Inc (CRMD) United States $0.281B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.274B 0.00
Rani Therapeutics Holdings (RANI) United States $0.263B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.263B 0.00
Zura Bio (ZURA) United States $0.261B 0.00
Prima BioMed (IMMP) Australia $0.260B 0.00
XBiotech (XBIT) United States $0.257B 0.00
Codexis (CDXS) United States $0.255B 0.00
ChromaDex (CDXC) United States $0.249B 0.00
Design Therapeutics (DSGN) United States $0.249B 0.00
2seventy Bio (TSVT) United States $0.247B 0.00
UniQure (QURE) Netherlands $0.243B 0.00
Coherus BioSciences (CHRS) United States $0.243B 0.00
G1 Therapeutics (GTHX) United States $0.237B 0.00
Agenus (AGEN) United States $0.228B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.224B 0.00
Ovid Therapeutics (OVID) United States $0.223B 0.00
Compass Therapeutics (CMPX) United States $0.220B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.219B 0.00
Innate Pharma S.A (IPHA) France $0.219B 0.00
Boundless Bio (BOLD) $0.215B 0.00
INmune Bio (INMB) United States $0.215B 0.00
Werewolf Therapeutics (HOWL) United States $0.205B 0.00
Opthea (OPT) Australia $0.199B 0.00
Inventiva S.A (IVA) France $0.199B 0.00
Puma Biotechnology (PBYI) United States $0.198B 12.41
Elevation Oncology (ELEV) United States $0.197B 0.00
Trevi Therapeutics (TRVI) United States $0.195B 0.00
GENFIT S.A (GNFT) France $0.187B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.186B 0.00
Compugen (CGEN) Israel $0.183B 0.00
Greenwich LifeSciences (GLSI) United States $0.180B 0.00
Lifecore Biomedical (LFCR) United States $0.178B 0.00
Kodiak Sciences (KOD) United States $0.173B 0.00
ScPharmaceuticals (SCPH) United States $0.171B 0.00
Alimera Sciences (ALIM) United States $0.168B 0.00
Adverum Biotechnologies (ADVM) United States $0.167B 0.00
Cellectis S.A (CLLS) France $0.166B 0.00
Scilex Holding (SCLX) United States $0.163B 0.00
Cardiff Oncology (CRDF) United States $0.162B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.158B 0.00
Gossamer Bio (GOSS) United States $0.157B 0.00
X4 Pharmaceuticals (XFOR) United States $0.156B 0.00
TELA Bio (TELA) United States $0.155B 0.00
Repare Therapeutics (RPTX) Canada $0.151B 0.00
CervoMed (CRVO) United States $0.149B 0.00
Sagimet Biosciences (SGMT) United States $0.147B 0.00
CytomX Therapeutics (CTMX) United States $0.147B 9.45
Syros Pharmaceuticals (SYRS) United States $0.146B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.143B 0.00
Renovaro (RENB) United States $0.143B 0.00
I-Mab (IMAB) China $0.142B 0.00
Cartesian Therapeutics (RNAC) United States $0.141B 0.00
Rapt Therapeutics (RAPT) United States $0.141B 0.00
Akoya Biosciences (AKYA) United States $0.141B 0.00
Seres Therapeutics (MCRB) United States $0.139B 0.00
ATyr Pharma (LIFE) United States $0.138B 0.00
Molecular Partners AG (MOLN) Switzerland $0.137B 0.00
Seer (SEER) United States $0.137B 0.00
BioAtla (BCAB) United States $0.136B 0.00
Sangamo Therapeutics (SGMO) United States $0.135B 0.00
Omega Therapeutics (OMGA) United States $0.133B 0.00
BioStem Technologies (BSEM) $0.133B 0.00
Vigil Neuroscience (VIGL) United States $0.132B 0.00
Adicet Bio (ACET) United States $0.131B 0.00
PDS Biotechnology (PDSB) United States $0.128B 0.00
Coya Therapeutics (COYA) United States $0.128B 0.00
Allakos (ALLK) United States $0.128B 0.00
Vor Biopharma (VOR) $0.124B 0.00
Abeona Therapeutics (ABEO) United States $0.120B 0.00
DiaMedica Therapeutics (DMAC) United States $0.120B 0.00
VistaGen Therapeutics (VTGN) United States $0.120B 0.00
Nuvectis Pharma (NVCT) United States $0.113B 0.00
Bluebird Bio (BLUE) United States $0.113B 0.00
DBV Technologies S.A (DBVT) France $0.113B 0.00
Adagene (ADAG) China $0.113B 0.00
Immunic (IMUX) United States $0.112B 0.00
BioHarvest Sciences (CNVCF) Canada $0.112B 0.00
Rezolute (RZLT) United States $0.106B 0.00
BeyondSpring (BYSI) United States $0.104B 0.00
Elicio Therapeutics (ELTX) United States $0.103B 0.00
Oncobiologics (OTLK) United States $0.101B 0.00
Q32 Bio (QTTB) United States $0.099B 0.00
Genelux (GNLX) United States $0.099B 0.00
Connect Biopharma Holdings (CNTB) United States $0.098B 0.00
Clearside Biomedical (CLSD) United States $0.098B 0.00
Athira Pharma (ATHA) United States $0.097B 0.00
InflaRx (IFRX) Germany $0.096B 0.00
China Health Industries Holdings (CHHE) China $0.095B 0.00
Eton Pharmaceuticals (ETON) United States $0.093B 90.50
Annovis Bio (ANVS) United States $0.093B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.093B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.091B 0.00
YS Biopharma (YS) China $0.091B 0.00
IO Biotech (IOBT) Denmark $0.091B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.091B 0.00
Benitec Biopharma (BNTC) United States $0.089B 0.00
Precision BioSciences (DTIL) United States $0.086B 0.00
Spero Therapeutics (SPRO) United States $0.086B 3.12
Gritstone Bio (GRTS) United States $0.085B 0.00
Galena Biopharma (SLS) United States $0.084B 0.00
Oncolytics Biotech (ONCY) Canada $0.084B 0.00
VTv Therapeutics (VTVT) United States $0.084B 0.00
Cue Biopharma (CUE) United States $0.083B 0.00
Aileron Therapeutics (ALRN) United States $0.081B 0.00
Passage Bio (PASG) United States $0.081B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.081B 0.00
HOOKIPA Pharma (HOOK) United States $0.081B 0.00
Elutia (ELUT) United States $0.080B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.080B 0.00
Affimed (AFMD) Germany $0.080B 0.00
Cognition Therapeutics (CGTX) United States $0.079B 0.00
BioXcel Therapeutics (BTAI) United States $0.078B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.077B 0.00
Bionano Genomics (BNGO) United States $0.076B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.075B 0.00
Instil Bio (TIL) United States $0.075B 0.00
Atara Biotherapeutics (ATRA) United States $0.073B 0.00
Rallybio (RLYB) United States $0.073B 0.00
Alpha Teknova (TKNO) United States $0.073B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.073B 0.00
Landos Biopharma (LABP) United States $0.070B 0.00
MediciNova (MNOV) United States $0.070B 0.00
Curis (CRIS) United States $0.070B 0.00
Ikena Oncology (IKNA) United States $0.069B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.068B 0.00
AN2 Therapeutics (ANTX) United States $0.068B 0.00
Leap Therapeutics (LPTX) United States $0.067B 0.00
Checkpoint Therapeutics (CKPT) United States $0.067B 0.00
Intensity Therapeutics (INTS) United States $0.067B 0.00
Immix Biopharma (IMMX) United States $0.065B 0.00
Lantern Pharma (LTRN) United States $0.065B 0.00
AVROBIO (AVRO) United States $0.062B 0.00
Turnstone Biologics (TSBX) United States $0.062B 0.00
Kronos Bio (KRON) United States $0.061B 0.00
Ocean Biomedical (OCEA) United States $0.061B 0.00
Theratechnologies (THTX) Canada $0.061B 0.00
Earth Science Tech (ETST) United States $0.060B 0.00
Genenta Science S.p.A (GNTA) Italy $0.060B 0.00
LENZ Therapeutics (LENZ) United States $0.060B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.060B 0.00
CalciMedica (CALC) United States $0.059B 0.00
Celularity (CELU) United States $0.058B 0.00
Enzo Biochem (ENZ) United States $0.056B 0.00
Kezar Life Sciences (KZR) United States $0.056B 0.00
Equillium (EQ) United States $0.055B 0.00
Aligos Therapeutics (ALGS) United States $0.054B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.053B 0.00
Cidara Therapeutics (CDTX) United States $0.051B 0.00
Beyond Air (XAIR) United States $0.049B 0.00
Dare Bioscience (DARE) United States $0.049B 0.00
ARCA Biopharma (ABIO) United States $0.048B 0.00
Dyadic (DYAI) United States $0.048B 0.00
Clene (CLNN) United States $0.048B 0.00
Aadi Bioscience (AADI) United States $0.047B 0.00
NextCure (NXTC) United States $0.047B 0.00
IN8bio (INAB) United States $0.045B 0.00
OKYO Pharma (OKYO) $0.044B 0.00
Ocuphire Pharma (OCUP) United States $0.044B 0.00
Immuneering (IMRX) United States $0.044B 0.00
Xilio Therapeutics (XLO) United States $0.042B 0.00
HCW Biologics (HCWB) United States $0.042B 0.00
Cara Therapeutics (CARA) United States $0.041B 0.00
Lexaria Bioscience (LEXX) Canada $0.041B 0.00
Eyenovia (EYEN) United States $0.040B 0.00
Cyclo Therapeutics (CYTH) United States $0.040B 0.00
Carmell (CTCX) United States $0.039B 0.00
Quince Therapeutics (QNCX) United States $0.039B 0.00
Fortress Biotech (FBIO) United States $0.038B 0.00
Sensei Biotherapeutics (SNSE) United States $0.038B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.038B 0.00
Estrella Immunopharma (ESLA) United States $0.037B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.036B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.036B 0.00
MiNK Therapeutics (INKT) United States $0.035B 0.00
Promis Neurosciences (PMN) Canada $0.035B 0.00
SAB Biotherapeutics (SABS) United States $0.033B 0.00
Pluri (PLUR) Israel $0.033B 0.00
RenovoRx (RNXT) United States $0.033B 0.00
Spruce Biosciences (SPRB) United States $0.031B 0.00
Bolt Biotherapeutics (BOLT) United States $0.030B 0.00
Apollomics (APLM) United States $0.030B 0.00
Aprea Therapeutics (APRE) United States $0.029B 0.00
Femasys (FEMY) United States $0.028B 0.00
Evogene (EVGN) Israel $0.027B 0.00
BioAffinity Technologies (BIAF) United States $0.026B 0.00
Biora Therapeutics (BIOR) United States $0.026B 0.00
NKGen Biotech (NKGN) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.023B 0.00
BRIACELL THERAP (BCTX) Canada $0.022B 0.00
Forte Biosciences (FBRX) United States $0.022B 0.00
Lumos Pharma (LUMO) United States $0.021B 0.00
Evaxion Biotech (EVAX) Denmark $0.020B 0.00
Cocrystal Pharma (COCP) United States $0.020B 0.00
Synlogic (SYBX) United States $0.019B 0.00
Aptose Biosciences (APTO) Canada $0.019B 0.00
Orgenesis (ORGS) United States $0.019B 0.00
KALA BIO (KALA) United States $0.018B 0.00
VBI Vaccines (VBIV) United States $0.018B 0.00
Senti Biosciences (SNTI) United States $0.017B 0.00
Galecto (GLTO) Denmark $0.017B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Vincerx Pharma (VINC) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.014B 0.00
Purple Biotech (PPBT) Israel $0.014B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.013B 0.00
Semper Paratus Acquisition (TVGN) United States $0.013B 0.00
Elevai Labs (ELAB) United States $0.013B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.012B 0.00
Moleculin Biotech (MBRX) United States $0.012B 0.00
ABVC BioPharma (ABVC) United States $0.011B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Galera Therapeutics (GRTX) United States $0.011B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.010B 0.00
NuCana (NCNA) United Kingdom $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Chemomab Therapeutics (CMMB) Israel $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
Vaccinex (VCNX) United States $0.009B 0.00
Kintara Therapeutics (KTRA) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Psyence Biomedical (PBM) United States $0.008B 0.00
Telesis Bio (TBIO) United States $0.008B 0.00
Trevena (TRVN) United States $0.007B 0.00
Bionomics (BNOX) Australia $0.007B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.007B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.007B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Virios Therapeutics (VIRI) United States $0.007B 0.00
TFF Pharmaceuticals (TFFP) United States $0.007B 0.00
Atrinsic (PTIX) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Palisade Bio (PALI) United States $0.006B 0.00
Synaptogenix (SNPX) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Kineta (KA) United States $0.006B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Cingulate (CING) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
ThermoGenesis Holdings (THMO) United States $0.005B 0.00
Novogen (KZIA) Australia $0.005B 0.00
Artelo Biosciences (ARTL) United States $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Alzamend Neuro (ALZN) United States $0.004B 0.00
Exicure (XCUR) United States $0.004B 0.29
Tharimmune (THAR) United States $0.004B 0.00
Seelos Therapeutics (SEEL) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.41
TC BioPharm (Holdings) (TCBP) United Kingdom $0.004B 0.00
Onconetix (ONCO) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Mustang Bio (MBIO) United States $0.003B 0.00
Longeveron (LGVN) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00